CARLSBAD, Calif., April 12, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers ...
‒ Poster for GP2 Phase IIb clinical trial final efficacy analysis was presented during the 2020 San Antonio Breast Cancer Symposium (SABCS) today ‒ Phase IIb clinical trial was a prospective, ...
Images, graphs, and tables are wonderful ways to communicate information quickly and effectively to an audience. However, they must be presented and organized correctly to be useful. All images, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback